文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

对于有20个或更多脑转移瘤的患者,省略辅助全脑放射治疗的伽玛刀手术是否可行?

Is Gamma Knife surgery, omitting adjunct whole brain radiation treatment, feasible for patients with 20 or more brain metastases?

作者信息

Jiani Sherry Liu, Karlsson Bengt, Vellayappan Balamurugan, Ang Yvonne, Wu Peng, Yeo Tseng Tsai, Nga Vincent

机构信息

Department of Surgery, Division of Neurosurgery, National University Hospital, Singapore, Singapore.

Department of Radiation Oncology, National University Hospital, Singapore, Singapore.

出版信息

Neurooncol Adv. 2024 Mar 27;6(1):vdae047. doi: 10.1093/noajnl/vdae047. eCollection 2024 Jan-Dec.


DOI:10.1093/noajnl/vdae047
PMID:38873531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11170483/
Abstract

BACKGROUND: The importance of the number of brain metastases (BM) when deciding between whole brain radiation treatment (WBRT) and radiosurgery is controversial. We hypothesized that the number of BM is of limited importance when deciding radiation strategy, and offered Gamma Knife surgery (GKS) also for selected patients with 20 or more BM. METHODS: The outcome following single session GKS for 75 consecutive patients harboring 20 or more (20+) BM was analyzed. Data was collected both retro- and prospectively. RESULTS: The median survival time was 9 months. Two grade 3 complications occurred, 1 resolved and 1 did not. Sex and clinical condition at the time of GKS (ECOG value) were the only parameters significantly related to survival time. Eighteen patients developed leptomeningeal dissemination with or without distant recurrences (DR), and another 32 patients developed DR a total of 73 times. DR was managed with GKS 24 times, with WBRT 3 times and with systemic treatment or best supportive care 46 times. The median time to developing DR was unrelated to the number of BM, but significantly longer for patients older than 65 years, as well as for patients with NSCLC. CONCLUSIONS: GKS is a reasonable treatment option for selected patients with 20 or more BM. It is better to decide the optimal management of post-GKS intracranial disease progression once it occurs rather than trying to prevent it by using adjunct WBRT.

摘要

背景:在决定采用全脑放射治疗(WBRT)还是放射外科手术时,脑转移瘤(BM)数量的重要性存在争议。我们假设在决定放射治疗策略时,BM数量的重要性有限,并为部分有20个或更多BM的患者提供了伽玛刀手术(GKS)。 方法:分析了连续75例有20个或更多(20+)BM的患者单次接受GKS后的结果。数据通过回顾性和前瞻性方式收集。 结果:中位生存时间为9个月。发生了2例3级并发症,1例缓解,1例未缓解。GKS时的性别和临床状况(东部肿瘤协作组[ECOG]评分)是与生存时间显著相关的唯一参数。18例患者出现了软脑膜播散,伴或不伴有远处复发(DR),另有32例患者共发生73次DR。DR采用GKS治疗24次,采用WBRT治疗3次,采用全身治疗或最佳支持治疗46次。发生DR的中位时间与BM数量无关,但65岁以上患者以及非小细胞肺癌(NSCLC)患者的时间显著更长。 结论:对于部分有20个或更多BM的患者,GKS是一种合理的治疗选择。最好在GKS后颅内疾病进展发生时决定最佳治疗方案,而不是试图通过辅助WBRT来预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d60/11170483/eadf5f5a713c/vdae047_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d60/11170483/594068e0d961/vdae047_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d60/11170483/c9e0e6671452/vdae047_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d60/11170483/eadf5f5a713c/vdae047_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d60/11170483/594068e0d961/vdae047_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d60/11170483/c9e0e6671452/vdae047_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d60/11170483/eadf5f5a713c/vdae047_fig3.jpg

相似文献

[1]
Is Gamma Knife surgery, omitting adjunct whole brain radiation treatment, feasible for patients with 20 or more brain metastases?

Neurooncol Adv. 2024-3-27

[2]
Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.

J Neurosurg. 2017-8-18

[3]
Salvage treatment of distant recurrent brain metastases with Gamma Knife surgery.

Acta Neurochir (Wien). 2011-12-7

[4]
Large intracranial metastatic tumors treated by Gamma Knife surgery: outcomes and prognostic factors.

J Neurosurg. 2013-10-25

[5]
Radiation dose and incidence of new metastasis in the anterior temporal lobe structures of radiosurgically treated patients.

J Neurosurg. 2010-1

[6]
Incidence, timing, and treatment of new brain metastases after Gamma Knife surgery for limited brain disease: the case for reducing the use of whole-brain radiation therapy.

J Neurosurg. 2011-3-18

[7]
Survival following gamma knife radiosurgery for brain metastasis from breast cancer.

Radiat Oncol. 2013-5-29

[8]
Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas.

J Neurosurg. 2014-12

[9]
Gamma knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy.

J Neurosurg. 2000-12

[10]
Salvage gamma knife radiosurgery for active brain metastases from small-cell lung cancer after whole-brain radiation therapy: a retrospective multi-institutional study (JLGK1701).

J Neurooncol. 2020-1-13

本文引用的文献

[1]
Single-Session Gamma Knife Radiosurgery for Patients With 20 or More Brain Metastases.

Neurosurgery. 2023-10-1

[2]
How many brain metastases can be treated with stereotactic radiosurgery before the radiation dose delivered to normal brain tissue rivals that associated with standard whole brain radiotherapy?

J Appl Clin Med Phys. 2023-3

[3]
Two-staged gamma knife radiosurgery for treatment of numerous (>10) brain metastases.

Clin Neurol Neurosurg. 2020-8

[4]
Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease.

Adv Radiat Oncol. 2019-8-5

[5]
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors.

Neurosurgery. 2019-3-1

[6]
Does Modern Management of Malignant Extracranial Disease Prolong Survival in Patients with ≥3 Brain Metastases?

World Neurosurg. 2016-8

[7]
Leukoencephalopathy in long term brain metastases survivors treated with radiosurgery.

J Neurooncol. 2016-1

[8]
Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.

Lancet Oncol. 2014-3-10

[9]
Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer.

Cancer. 2012-6-15

[10]
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Lancet Oncol. 2009-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索